Visa-free extension heralds new era of Malaysia-China relations
Travellers are pictured at KLIA in Sepang on April 1, 2022. – Malay Mail photo
KUALA LUMPUR (April 26): The extension of visa-free travel between Malaysia and China is a strategic move that not only reflects deepening bilateral ties but also promises to boost cross-sectoral cooperation in tourism, education, and business, experts said.
The arrangement is expected to significantly enhance people-to-people connections, enabling deeper cultural exchange, understanding, and academic ties between the two nations.
Universiti Malaya's Asia-Europe Institute (AEI) Deputy Executive Director, Associate Prof Dr Roy Anthony Rogers, said the mutual visa exemption will not only benefit both governments and businesses, but also pave the way for greater opportunities to strengthen people-to-people connections.
'The visa exemption will increase the flow of people, which is something we should encourage, because for the past 50 years, bilateral relations have been too focused on government-to-government engagement.
'It is time to promote second and third track diplomacy through this visa exemption,' he told Bernama.
Echoing similar views, Chairman of the Centre for Regional Strategic Studies (CROSS), Lee Chean Chung, said the decision underscored the robust bilateral ties between the two nations, shaped by mutual trust and confidence.
He said the initiative is poised to effectively promote economic growth across sectors such as tourism, academic collaboration, and healthcare tourism.
'This will allow a wider array of Chinese visitors to Malaysia, encompassing not only tourists but also parents accompanying students, and individuals seeking medical treatment.
'This extended stay supports longer staycations and short-term visits, potentially ranging from a couple of weeks to a month, which is undoubtedly positive news for Malaysia's tourism sector,' he told Bernama.
'When visits are short, interactions are limited. With more time, visitors can immerse themselves more deeply in the local culture and communities,' he added.
Likewise, Lee said the agreement will also open opportunities for Malaysians to explore China more extensively.
'Previously, due to time constraints, many only visited coastal cities. Now, there's an opportunity to venture further inland and truly understand each other's cultures,' he said.
During Chinese President Xi Jinping's state visit here recently, Malaysia and China signed 31 Memorandum of Understanding (MoUs), notes, and cooperation agreements spanning various sectors.
Among them was an agreement on mutual visa exemption for holders of public affairs and ordinary passports, exchanged between Malaysia's Home Minister Datuk Seri Saifuddin Nasution Ismail and China's Foreign Minister Wang Yi.
On April 22, Saifuddin announced that the Malaysia–China visa-free period would be extended for five years.
Under the Visa Liberalisation Plan (PLV), Chinese nationals entering Malaysia as tourists may stay for up to 90 days visa-free, with China reciprocating the arrangement. – Bernama China tourism travel visa-free
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Malaysian Reserve
an hour ago
- Malaysian Reserve
ZBIO Deadline: ZBIO Investors with Losses in Excess of $100K Have Opportunity to Lead Zenas BioPharma, Inc. Securities Lawsuit Filed by The Rosen Law Firm
NEW YORK, June 6, 2025 /PRNewswire/ — Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Zenas BioPharma, Inc. (NASDAQ: ZBIO) pursuant and/or traceable to the registration statement and prospectus (collectively, the 'Registration Statement') issued in connection with Zenas BioPharma's September 2024 initial public offering ('IPO' or the 'Offering'), of the important June 16, 2025 lead plaintiff deadline in the securities class action first filed by the Firm. So What: If you purchased Zenas BioPharma securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. What to do next: To join the Zenas BioPharma class action, go to or call Phillip Kim, Esq. toll-free at 866-767-3653 or email case@ for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than June 16, 2025. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. Why Rosen Law: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers. Details of the case: According to the lawsuit, the Registration Statement contained false and/or misleading statements and/or failed to disclose that: (1) Zenas BioPharma materially overstated the amount of time it would be able to fund its operations using existing cash and expected net proceeds from the IPO; and (2) as a result, defendants' public statements were materially false and misleading at all relevant times and negligently prepared. When the true details entered the market, the lawsuit claims that investors suffered damages. To join the Zenas BioPharma action, go to or call Phillip Kim, Esq. toll-free at 866-767-3653 or email case@ for information on the class action. No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff. Follow us for updates on LinkedIn: on Twitter: or on Facebook: Attorney Advertising. Prior results do not guarantee a similar outcome. Contact Information: Laurence Rosen, Esq. Phillip Kim, Esq. The Rosen Law Firm, P.A. 275 Madison Avenue, 40th Floor New York, NY 10016 Tel: (212) 686-1060 Toll Free: (866) 767-3653 Fax: (212) 202-3827 case@
New Straits Times
3 hours ago
- New Straits Times
Slow traffic across major routes as Aidiladha travel peaks
KUALA LUMPUR: Traffic remains heavy on several major highways as increased numbers of vehicles leave the federal capital ahead of Hari Raya Aidiladha today. A spokesman for PLUS Malaysia Berhad (PLUS) said that as of 10.30pm yesterday, slow-moving traffic was reported on the North-South Expressway (NSE) and Kuala Lumpur-Karak (KLK) Expressway. "In addition, slow-moving traffic was also detected on the PLUS E2 northbound route from Skudai Toll Plaza to Sedenak and from Yong Peng to Pagoh, while southbound traffic was slow from Southville City to the Seremban Rest and Service Area and from Bandar Ainsdale to Senawang. "For the PLUS E1 route, northbound delays are expected from Bukit Lanjan to Rawang, Sungkai to Bidor, Bidor to Tapah, Tapah to Gopeng, and Perai to Bertam," the spokesman told Bernama. The Malaysian Highway Authority (LLM) reported congestion eastbound on the KLK Expressway from Gombak to Bukit Tinggi and from Lentang to Bentong via its social media platform. The public can obtain the latest traffic updates via the toll-free PLUSLine at 1-800-88-0000, the X platform @plustrafik, the LLM Info Trafik WhatsApp channel, or X @llmtrafik. Meanwhile, in Kelantan, traffic at the Gua Musang-Kuala Lipis and Terengganu-Kelantan border checkpoints remained smooth as of 9.30pm, following earlier congestion. A state police spokesperson confirmed that officers had been deployed to monitor and control traffic flow at both border checkpoints to ensure smooth travel.– BERNAMA
New Straits Times
5 hours ago
- New Straits Times
US-China trade talks to resume in seven days: White House
WASHINGTON: Trade negotiations between US and Chinese officials are expected to resume within seven days, following a phone call between President Donald Trump and President Xi Jinping. The discussions will place particular emphasis on rare earth minerals, White House Trade Adviser Peter Navarro confirmed on Friday. "We expect that a meeting will take place within seven days," Navarro told reporters at the White House, commenting on the timeline of the next round of trade talks. Navarro stated that Trump has been clear that "the rare earth issue will be key to that negotiation", as reported by Sputnik/RIA Novosti. The US delegation will include Trade Representative Jamieson Greer, Treasury Secretary Scott Bessent, and Secretary of Commerce Howard Lutnick, according to Navarro. The advisor also mentioned that Thursday's call between Trump and Xi lasted approximately 90 minutes, during which both leaders demonstrated "a very clear understanding" of the expected outcomes of the upcoming discussions. Trump later shared on Truth Social that he had discussed "some of the intricacies" of the US-China trade deal with President Xi. He also announced that he had accepted Xi's invitation to visit China and extended a reciprocal invitation. Following high-level trade and economic talks in Geneva earlier in May, Washington and Beijing agreed to lower reciprocal tariffs by 115 percentage points each for 90 days. The US has reduced tariffs on Chinese goods from 145 per cent to 30 per cent, while China has cut tariffs on American imports from 125 per cent to 10 per cent. Later that month, Trump accused China of "totally violating" the Geneva agreement and remarked that "it is extremely hard" to reach a deal with Beijing.–BERNAMA
